Melatonin MT1 receptor effectively inhibited the expression of integrin α2β1 and the transcriptional activities of FAK, C-SRC, and NF-κB, thereby reducing the migration and invasion ability of prostate cancer cells [143]. This evidence concerns the gene NFKB1 and prostate carcinoma.